Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06008756
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-08-17
Brief Title:
Enlicitide Decanoate MK-0616 Oral PCSK9 Inhibitor Cardiovascular Outcomes Study MK-0616-015 CORALreef Outcomes
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2029-11-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-11-29
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-17
First Submit QC Date:
August 17 2023
Study First Post Date:
2023-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL